Journal of Molecular and Cellular Cardiology
Volume 48, Issue 6 , Pages 1316-1323 , June 2010

PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue

  • Marius Vantler

      Affiliations

    • Klinik III für Innere Medizin, Universität zu Köln, Germany
    • Center for Molecular Medicine (CMMC), Universität zu Köln, Germany
    • These authors contributed equally.
    • ,
  • Bijoy Chandapillai Karikkineth

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • These authors contributed equally.
    • ,
  • Hiroshi Naito

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • These authors contributed equally.
    • ,
  • Malte Tiburcy

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • Department of Pharmacology, Heart Research Center Göttingen, Georg-August-University Göttingen, Germany
    • ,
  • Michael Didié

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • Department of Pharmacology, Heart Research Center Göttingen, Georg-August-University Göttingen, Germany
    • ,
  • Monika Nose

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Stephan Rosenkranz

      Affiliations

    • Klinik III für Innere Medizin, Universität zu Köln, Germany
    • Center for Molecular Medicine (CMMC), Universität zu Köln, Germany
    • Corresponding Author InformationCorrespondimg authors. Rosenkranz is to be contacted at Klinik III für Innere Medizin, Universität zu Köln, Germany. Zimmermann, University Medical Center Goettingen, Department of Pharmacology, Robert-Koch-Str. 40, 37075 Goettingen, Germany. Tel.: +49 551 39 5781; fax: +49 551 39 5699.
    • ,
  • Wolfram-H. Zimmermann

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    • Department of Pharmacology, Heart Research Center Göttingen, Georg-August-University Göttingen, Germany
    • Corresponding Author InformationCorrespondimg authors. Rosenkranz is to be contacted at Klinik III für Innere Medizin, Universität zu Köln, Germany. Zimmermann, University Medical Center Goettingen, Department of Pharmacology, Robert-Koch-Str. 40, 37075 Goettingen, Germany. Tel.: +49 551 39 5781; fax: +49 551 39 5699.
    • Current address: School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, India - 721302.

Received 13 October 2009 ,Revised 26 February 2010 ,Accepted 15 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-2828(10)00093-3

doi: 10.1016/j.yjmcc.2010.03.008

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 6 , Pages 1316-1323 , June 2010

Article Tools

* Image Usage & Resolution